Loading...

Cresco Labs Inc.

CRLBF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$1.32
$0.08(6.84%)

Cresco Labs Inc. (CRLBF) Stock Overview

Explore Cresco Labs Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 69.9/100

Key Financials

Market Cap449.3M
P/E Ratio-10.32
EPS (TTM)$-0.14
ROE-0.10%
Fundamental Analysis

AI Price Forecasts

1 Week$0.50
1 Month$0.39
3 Months$0.96
1 Year Target$0.09

CRLBF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cresco Labs Inc. (CRLBF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 74.77, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.09.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -10.32 and a market capitalization of 449.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.77%
5-Day Change
-16.47%
1-Month Change
-20.55%
3-Month Change
-39.13%
6-Month Change
-64.90%
Year-to-Date (YTD) Change
-39.70%
1-Year Change
-73.63%
3-Year Change
-89.93%
5-Year Change
-80.97%
All-Time (Max) Change
-88.47%

Contact Information

https://www.crescolabs.com
312 929 0993
400 West Erie Street, Chicago, IL, 60654

Company Facts

2,900 Employees
IPO DateDec 3, 2018
CountryUS
Actively Trading

Frequently Asked Questions

;